A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas
Daiichi Sankyo
Mrinal M Gounder; Todd M Bauer; Gary K Schwartz; Amy M Weise; Patricia LoRusso; Prasanna Kumar; Ben Tao; Ying Hong; Parul Patel; Yasong Lu; Arnaud Lesegretain; Vijaya G Tirunagaru; Feng Xu; Robert C Doebele; David S Hong